View Post

Long Haul for Breast Cancer Survivors: Disease Can Return After 20 Years

In In The News by Barbara Jacoby

From: healthline.com New research shows that long-term endocrine therapy can reduce the risk of breast cancer recurrence in the long term. But side effects keep some women from taking it. Like many breast cancer survivors, Julie Barthels wonders if the disease will return. “My breast cancer came silently, without my knowledge. How do I know what is silently growing inside …

View Post

Hormonal therapy for breast cancer can also increase risk of developing chronic conditions

In In The News by Barbara Jacoby

By: Elisa Black From: news.com.au WOMEN who receive hormonal therapy for breast cancer are at increased risk of developing chronic conditions later in life. New research by Flinders University and the University of South Australia, published in the Medical Journal of Australia yesterday, found that rates of depression, osteoporosis, diabetes, cardiovascular conditions, chronic pain and gastric disorders were higher among …

View Post

ASCO: Studies Demonstrate Predictive Power of bioTheranostics’ Breast Cancer Index Molecular Test in Treatment Decisions

In In The News by Barbara Jacoby

Ability to Predict Benefit from Extended Endocrine Therapy Impacts Treatment & Reduces Patient Anxiety bioTheranostics, Inc., today announced results from studies being presented at the 2015 American Society of Clinical Oncology (ASCO) meeting reinforcing the role its Breast Cancer Index (BCI) molecular test plays in informing decisions about extending endocrine therapy beyond five years post-diagnosis for patients with early stage, estrogen receptor-positive …